Healthcare & Life Sciences
Seahorse Bioscience
United States
acquired
acquired
Stage
1
Investors
About
Seahorse Bioscience, founded in 2001, provided instruments and assay kits to measure cell metabolism and bioenergetics for research into neurodegeneration, aging, cancer, cardiovascular disease and other biological processes. The company was acquired by Agilent Technologies in 2015.
Explore Seahorse Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.